Quantify the functional layer of biology.
Proteins execute the programmes your genomics predicts. Orbitrap LC-MS/MS identifies and quantifies thousands of proteins per sample, for biomarker discovery, mechanism, PTM mapping and biopharma characterisation. Mass spectrometry runs at our partner laboratory; study design, data analysis and reporting are done by our team in Hyderabad.
Proteomics Services at Nucleome Informatics
LC-MS/MS runs on Thermo Scientific Orbitrap high-resolution mass spectrometers with nano/UHPLC separation at our partner laboratory. Nucleome designs the study, coordinates sample QC and shipping, and carries out the full data analysis and reporting in-house.
We cover the standard quantitative workflows: DDA discovery, DIA cohort quantitation, TMT multiplexing, targeted PRM, and phospho-, ubiquitin- and acetyl-PTM enrichment. Abundance tables are where the biology starts, so every project goes through our analysis pipeline, from raw protein abundance tables to functional interpretation.
- Raw data plus processed protein and peptide quantitation tables at 1% FDR (PSM level)
- Differential abundance analysis with multiple-testing correction
- PTM site localisation, scored by localisation probability, for phospho, acetyl and ubiquitin workflows
- Gene Ontology and pathway enrichment on protein lists
- QC documentation: standard digest performance, peptide and protein IDs, quantitative CVs
- A written analysis report with search parameters, database versions and interpretation notes
The analysis pipeline (included with every project)
- Import and harmonisation: protein abundance tables, with QC of identification frequency, sample coverage and reproducibility.
- Variance-stabilising normalisation (VSN): calibrates samples so variation is comparable across intensity ranges.
- MNAR-appropriate imputation (MinProb-class): missing values in label-free data concentrate at low intensity (missing-not-at-random), so imputation is chosen accordingly.
- Differential testing on a limma framework: borrows information across proteins to stabilise variance in small experiments.
- Visualisation: PCA, correlation analysis, volcano plots and heatmaps.
- Functional enrichment: GO (biological process, cellular component, molecular function) and KEGG pathways.
- Honest identification control: 1% FDR by decoy-database search, with protein groups reported where shared peptides make inference ambiguous.
From first principles to expert-level analysis
New here? Start with Foundations. Planning a study or reviewing results? Jump to Practitioner or Expert. Each level builds on the one before it, so you can read this page as a short course or dip in where you need to.
Start here if you are new to this service: six ideas that explain what it is and why it matters.
What is proteomics?
The systematic measurement of proteins in a sample: their identity, abundance and modifications. Proteins carry out the programmes encoded in the genome, so proteomics shows what the genome is actually doing.
What is an Orbitrap?
A high-resolution mass spectrometer that measures peptide masses very accurately, which makes it possible to identify thousands of proteins per run with confidence.
What is LC-MS/MS?
Liquid chromatography separates peptides; the mass spectrometer measures them and fragments them (MS/MS) to read their sequence. Together they identify and quantify proteins.
DDA vs DIA: which do I need?
DDA maximises identification depth for discovery; DIA gives more reproducible quantitation across many samples. Cohort studies usually favour DIA; mechanism and discovery projects often start with DDA.
What samples can I analyse?
Cells, tissues, plasma or serum, immunoprecipitates, secretomes, and plant or microbial samples, with preparation matched to the sample type.
What will I get?
Protein and peptide quantitation tables with FDR statistics, differential analysis, pathway enrichment and a written report, plus the raw data.
For researchers planning a study: the design choices that shape your results.
Choosing a quantitation mode
Few samples and a discovery question: DDA or TMT. Larger cohorts: DIA. A short list of candidate proteins to confirm: targeted PRM. We recommend the mode at the design call.
Replicates
Plan at least three biological replicates per group. Clinical and plasma studies need more, because biological variation between people is larger than technical variation.
Plasma and serum
A few abundant proteins such as albumin and immunoglobulins dominate the signal. Depletion or fractionation increases depth, at the cost of throughput and cost per sample.
PTM studies
Modified peptides are rare, so PTM work needs more starting material and an enrichment step. Collect samples with protease and phosphatase inhibitors and process them quickly.
TMT designs
Isobaric tags let several samples run together in one multiplex. A pooled reference channel links multiplexes; ratio compression is expected with TMT and is reported.
Reading the results
Check QC first: proteins identified per sample, missing values and CVs. Then read the protein groups, fold changes and adjusted p-values in the differential table.
For bioinformaticians and specialists: what happens under the hood, and the terms used in our reports.
False discovery control
Spectra are searched against target and decoy databases, and identifications are filtered at 1% FDR. Proteins sharing peptides are reported as protein groups, not single names.
DIA analysis
DIA data are analysed library-free or against a spectral library. Per-run completeness is reported alongside quantitation so you can see where values are missing.
Missing values
In label-free data, values are mostly missing because a protein fell below detection (MNAR). MinProb-class imputation reflects that, and results are checked for sensitivity to the choice.
Normalisation and batches
VSN makes variance comparable across intensities. Randomised run order and QC standards keep batch effects measurable and correctable.
PTM site localisation
Each modification site carries a localisation probability. Site-level changes are interpreted alongside protein-level abundance, so a change in the protein is not mistaken for a change in modification.
Multi-omics integration
Protein results can be linked to transcriptomic, metabolomic and genomic data from the same samples through our OmniIntegrate pipeline.
- PSM
- Peptide-spectrum match: one MS/MS spectrum assigned to one peptide sequence.
- FDR
- False discovery rate: the expected share of incorrect identifications, estimated with decoy sequences.
- DDA
- Data-dependent acquisition: the instrument picks the most intense peptides to fragment.
- DIA
- Data-independent acquisition: all peptides in set mass windows are fragmented, run after run.
- TMT
- Tandem mass tags: isobaric labels that let several samples be measured together.
- PRM
- Parallel reaction monitoring: targeted, high-resolution quantitation of chosen peptides.
What to send us
Typical starting requirements per sample type. Final requirements are confirmed at project intake and depend on the workflow and sample; these amounts are starting points, not strict minimums.
| Sample type | Typical amount | Notes |
|---|---|---|
| Cell pellets | 1–5 × 10⁶ cells | Wash with PBS to remove media proteins |
| Tissue | 10–50 mg | Snap-frozen; for PTM work, rapid handling with inhibitors |
| Plasma / serum | 10–50 µL | Depletion and/or fractionation advised for depth |
| Immunoprecipitates | 10–100 µg protein | Include matched controls for interactomics |
| Secretome / conditioned media | 5–10 mL | Serum-free conditioning window before collection |
How the service works, step by step
Orbitrap-based LC-MS/MS is the established platform for deep proteome profiling, and FDR-based identification control and DIA quantitation are established practice in the proteomics literature. See the references below.
Why Orbitrap LC-MS/MS?
- Speed and sensitivity: high-resolution Orbitrap analysers with fast MS/MS duty cycles maximise peptide identification depth per unit time.
- Quantitative flexibility: one platform supports label-free, DIA, TMT and PRM, matched to cohort size and question.
- PTM capability: high mass accuracy and HCD fragmentation enable confident PTM site localisation.
Built for the questions you are asking
The platforms, pipelines and standards behind this service.
Thermo Orbitrap HRMS
High-resolution, high-mass-accuracy analysis with fast duty cycles at our partner laboratory: the backbone of deep proteome coverage.
Nano/UHPLC separation
Nano-flow and micro/UHPLC methods matched to sample amount and complexity, from cell lysates to plasma.
DDA discovery
Data-dependent acquisition for maximum identification depth in discovery experiments.
DIA quantitation
Data-independent acquisition for reproducible quantitation across large cohorts, library-free or library-based, with per-run completeness reported.
TMT multiplexing
Isobaric tagging for multiplexed relative quantitation, with internal referencing across conditions.
Targeted PRM
High-resolution targeted quantitation for candidate validation and defined protein panels.
What you receive
Every project ships with the complete deliverable set: data, analysis and documentation.
- Raw data files with full acquisition parameters
- Protein and peptide quantitation tables at 1% FDR (PSM level)
- Differential abundance analysis with adjusted p-values and fold changes
- PTM site tables with localisation probabilities (PTM workflows)
- GO and KEGG functional enrichment on protein lists
- QC documentation (standard digest performance, quantitative CVs) and a written methods report
Data analysis in pictures
Illustrative analyses showing what your project report contains. All data below are simulated for illustration, not client results.
What this service does and does not cover
Service highlights
What you can expect from our team in Hyderabad.
Orbitrap HRMS through our partner lab
Thermo Orbitrap high-resolution MS with nano/UHPLC, discovery and quantitation on one platform, with Nucleome managing the project end to end.
Full quantitation menu
DDA, DIA, TMT and PRM, matched to your cohort size and question.
1% FDR discipline
Identification control at PSM level, with search parameters and database versions reported.
PTM expertise
Phospho-, ubiquitin- and acetyl-proteomics with localisation-probability scoring.
Analysis in-house
Every dataset goes through our own pipeline and is reported by our scientists in Hyderabad.
Multi-omics ready
Integration with transcriptomics, metabolomics and genomics through our Bioinformatics service (OmniIntegrate).
Frequently asked, in plain language
From the basics to the finer points of design and interpretation.
BasicWhat is the difference between DDA and DIA?
BasicWhat samples do you accept?
BasicHow many proteins can you identify?
IntermediateCan you quantify proteins absolutely?
IntermediateDo you do PTM studies?
IntermediateHow do you control false discoveries?
AdvancedCan you handle plasma biomarker discovery?
AdvancedCan you run TMT multiplexing?
AdvancedCan proteomics integrate with my other omics data?
AdvancedDo you support non-model organisms?
Key literature & resources
Selected sources behind the methods and reference values on this page. Figures labelled "schematic" or "simulated" were made for this page and are not client data.
- Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537(7620):347–355.
- Eliuk S, Makarov A. Evolution of Orbitrap mass spectrometry instrumentation. Annual Review of Analytical Chemistry. 2015;8:61–80.
- Bantscheff M, et al. Quantitative mass spectrometry in proteomics: a critical review. Analytical and Bioanalytical Chemistry. 2007;389(4):1017–1031.
- Bruderer R, et al. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Molecular & Cellular Proteomics. 2015;14(5):1400–1410.
- Thompson A, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Analytical Chemistry. 2003;75(8):1895–1904.
- Peterson AC, et al. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Molecular & Cellular Proteomics. 2012;11(11):1475–1488.
- Mertins P, et al. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Molecular & Cellular Proteomics. 2014;13(7):1690–1704.
- The UniProt Consortium. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Research. 2023;51(D1):D523–D531.
- Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research. 2015;43(7):e47.
- Huber W, et al. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(Suppl 1):S96–S104.
- DEP: an R/Bioconductor package for differential enrichment analysis of label-free proteomics data. Bioconductor software package. bioconductor.org/packages/DEP









